4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000069
President and CEO sold 1,000 shares at $15.00 ($15,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2023-10-17 | Sale 10b5-1 | −1,000 | $15.00 | $15,000 | 247,279 | D |
| Open-market sales · 1,000 sh · avg $15.00 · $15,000 | |||||||
Loading xslF345X05/wk-form4_1697750861.xml…